Back to company

SPECIFIC PHARMA A/S: Financial statements 2025

CVR: 33161395

SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 219,329,000 and a net result of DKK 29,239,000 compared with DKK 25,560,000 the year before. That is an increase of 4% compared with the year before. The profit margin was 13.3%. Equity amounted to DKK 111,203,000. The solvency ratio was 82.7%. The company had 28 employees in the financial year.

Revenue
219,329,000 kr.
Gross Profit
57,275,000 kr.
Profit/Loss
29,239,000 kr.
Equity
111,203,000 kr.
Total Assets
134,475,000 kr.
Employees
28

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025219.3 mio.57.3 mio.29.2 mio.111.2 mio.28
2024211 mio.48.5 mio.25.6 mio.106.2 mio.25
2023177.6 mio.34.7 mio.9.9 mio.89.6 mio.25
2022123.3 mio.26.4 mio.7.8 mio.85.5 mio.23
2021139.6 mio.32.5 mio.14.8 mio.88.8 mio.21

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like SPECIFIC PHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

SPECIFIC PHARMA A/S appoints new auditorJun 26, 2025

As of June 26, 2025, Forvis Mazars Statsautoriseret Revisionspartnerselskab has been appointed auditor of SPECIFIC PHARMA A/S.

Auditor steps down at SPECIFIC PHARMA A/SJun 26, 2025

As of June 26, 2025, EY Godkendt Revisionspartnerselskab has stepped down as auditor of SPECIFIC PHARMA A/S.

About SPECIFIC PHARMA A/S

SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.